Rohit Thummalapalli

Also affiliated with Cornell University, Kettering University

MedicinePharmacology, Toxicology and PharmaceuticsBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer”.

Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1207

N/A

0.542DataRank · unranked

36 citations

Biagio Ricciuti, Chaitanya Bandlamudi, Daniel M. Muldoon, Hira Rizvi, Arielle Elkrief +23 more

Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non–Small Cell Lung Cancer

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2990

N/A

0.312DataRank · unranked

7 citations

Rohit Thummalapalli, Stephanie Alden, Biagio Ricciuti, Joao V. Alessi, Arielle Elkrief +18 more

Lorlatinib Tolerability and Association With Clinical Outcomes in Patients With Advanced ALK- or ROS1-Rearranged NSCLC: A Brief Report

JTO Clinical and Research Reports(2023)10.1016/j.jtocrr.2023.100546

N/A

0DataRank · unranked

4 citations

Noura J. Choudhury, Fiona Ehrich, Tyler Beardslee, Danielle Brazel, Shannon Zhang +8 more

Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis

medRxiv(2023)10.1101/2023.05.15.23289680

N/A

0DataRank · unranked

4 citations

Rohit Thummalapalli, Michael J. Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam +23 more

Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.29.560194

N/A

0DataRank · unranked

2 citations

Xueqian Zhuang, Chun‐Hao Pan, Yan Yan, Rohit Thummalapalli, Jill Hallin +12 more

Clinical and molecular features of long-term response to anti-PD-(L)1 therapy in patients with advanced non-small cell lung cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9107

N/A

0DataRank · unranked

0 citations

Biagio Ricciuti, Chaitanya Bandlamudi, Daniel M. Muldoon, Jia Luo, Joao Victor Machado Alessi +13 more

Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.01.012

N/A

0DataRank · unranked

42 citations

So Yeon Kim, Jacqueline V. Aredo, Jamie Feng, Frances A. Shepherd, Chao Xu +52 more

Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis

Nature Communications(2024)10.1038/s41467-023-44512-4

N/A

0DataRank · unranked

33 citations

Rohit Thummalapalli, Michael J. Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam +28 more

Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors

Annals of Oncology(2024)10.1016/j.annonc.2024.11.014

N/A

0DataRank · unranked

25 citations

Lingzhi Hong, Arielle Elkrief, Rohit Thummalapalli, Alissa J. Cooper, Biagio Ricciuti +43 more

Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer

Cell(2024)10.1016/j.cell.2024.11.010

N/A

0DataRank · unranked

19 citations

Maria Perry, Samuel I. Gould, Arielle Elkrief, Anton Safonov, Rohit Thummalapalli +23 more

Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS- Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2983

N/A

0DataRank · unranked

14 citations

Sydney Connor, Khaled Sanber, Marianna Zahurak, Tianbei Zhang, Isha Gurumurthy +24 more

Genomic landscape of MTAP deletions and association with EGFR alterations in NSCLC.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.8599

N/A

0DataRank · unranked

3 citations

Daniel M. Muldoon, Christopher A. Febres‐Aldana, Christina J. Falcon, Amanda Pupo, Chaitanya Bandlamudi +6 more

Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events

medRxiv(2024)10.1101/2024.06.10.24308518

N/A

0DataRank · unranked

2 citations

Rohit Thummalapalli, Zoe Quandt, Karmugi Balaratnam, Eduardo Cárdenas, Christina J. Falcon +13 more

Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-011273

N/A

0DataRank · unranked

7 citations

Rohit Thummalapalli, Zoe Quandt, Karmugi Balaratnam, Eduardo Cárdenas, Christina J. Falcon +13 more

Clinical Significance of MTAP Deletions and Their Overlap With Concurrent Oncogenic Driver Alterations Including EGFR in NSCLC

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.11.010

N/A

0DataRank · unranked

5 citations

Rohit Thummalapalli, Christopher A. Febres‐Aldana, Daniel M. Muldoon, Christina J. Falcon, Amanda Pupo +18 more

350P IDH2-mutated cholangiocarcinoma: A case series highlighting challenges and insights

Annals of Oncology(2025)10.1016/j.annonc.2025.05.365

N/A

0DataRank · unranked

1 citations

James J. Harding, Rohit Thummalapalli, D. Khalil, Amin Yaqubie, Eileen M. O’Reilly +2 more

Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung Adenocarcinoma

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0289

N/A

0DataRank · unranked

69 citations

Xueqian Zhuang, Chun‐Hao Pan, Yan Yan, Rohit Thummalapalli, Jill Hallin +12 more

Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms

medRxiv(2025)10.1101/2025.06.24.25330227

N/A

0DataRank · unranked

2 citations

Salomon Tendler, Joanne F. Chou, Zeynep Tarcan, Courtney Porfido, Jonathan Willner +20 more

Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer

The Oncologist(2023)10.1093/oncolo/oyad197

N/A

0DataRank · unranked

12 citations

Biagio Ricciuti, Joao V. Alessi, Teng Fei, Hannah L. Kalvin, Jacklynn V. Egger +16 more